Amedeo Smart

Free Medical Literature Service

 

Amedeo

Sepsis
  Free Subscription

Articles published in
Clin Infect Dis
    August 2026
  1. RHEE C, Masur H, Klompas M, Bell T, et al
    IDSA/ACEP/ASM/PIDS/SCCM/SHEA/SHM/SIDP Multisociety Position Paper: Hospital Strategies to Improve Sepsis Outcomes.
    Clin Infect Dis. 2026 Aug 25:ciag438. doi: 10.1093.
    >> Share

    July 2026
  2. YOSHIDA H, Adelman MW, Ifiora F, Perez MA, et al
    Utility of Repeating Blood Cultures in Candidemia: Insights From 2 Large Clinical Data Repositories.
    Clin Infect Dis. 2026;83:e105-e108.
    >> Share

  3. YAHAV D, Pinto R, Cook D, Davis J, et al
    Duration of Therapy for Pseudomonas aeruginosa Bacteremia-A Post Hoc Subgroup Analysis From the BALANCE Randomized Controlled Trial.
    Clin Infect Dis. 2026;83:41-47.
    >> Share

  4. GUPTA S, Klompas M, McKenna CS, Agan AA, et al
    Time to Antibiotics and Mortality in Immunocompromised versus Non-Immunocompromised Patients with Suspected Sepsis.
    Clin Infect Dis. 2026 Jul 15:ciag401. doi: 10.1093.
    >> Share

  5. CAREY-EWEND K, Shepard H, Yang G, Odas M, et al
    Frequent Plasmodium ovale Recurrence in Coastal Tanzania.
    Clin Infect Dis. 2026;82:1044-1051.
    >> Share

    June 2026
  6. KOWALKOWSKI M, Birken S, Obermiller C, Miller CD, et al
    Sepsis Diagnostic Excellence and its Association with Mortality in Adults with Potential Infection.
    Clin Infect Dis. 2026 Jun 30:ciag382. doi: 10.1093.
    >> Share

    April 2026
  7. MORGAN DJ, AlShanqeeti S, Coffey KC, Baghdadi JD, et al
    Using Generative Artificial Intelligence to Identify Central Line-associated Bloodstream Infections.
    Clin Infect Dis. 2026;82:e773-e780.
    >> Share

  8. COMBET M, Gautheret-Dejean A, Luyt CE, Weiss N, et al
    Clinical Features and Outcomes of Human Herpesvirus-6 DNAemia in Critically Ill Patients: A Retrospective Multicenter Analysis.
    Clin Infect Dis. 2026;82:698-708.
    >> Share

  9. KALIL AC, Cawcutt KA
    Can Influenza virus cause bacteremia, sepsis, and septic shock?
    Clin Infect Dis. 2026 Apr 21:ciag243. doi: 10.1093.
    >> Share

  10. GOLD JAW, Benedict K, Lyman M, Toda M, et al
    Candida glabrata emerges as the most common cause of candidemia: analysis of a large hospital-based database, United States, 2016-2024.
    Clin Infect Dis. 2026 Apr 13:ciag252. doi: 10.1093.
    >> Share

    March 2026
  11. MACKOW NA, Shao W, Ge L, Komarow L, et al
    Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections.
    Clin Infect Dis. 2026 Mar 6:ciag160. doi: 10.1093.
    >> Share

    February 2026
  12. RUFFIEUX Y, Andoh J, Haas AD, Chinogurei C, et al
    Association of Immunodeficiency and HIV Viremia with Cervical Precancer and Cancer Risk among Women with HIV in South Africa.
    Clin Infect Dis. 2026 Feb 14:ciag093. doi: 10.1093.
    >> Share

  13. LODISE TP, Garey KW, Aram JA, Nathanson BH, et al
    Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals.
    Clin Infect Dis. 2026;82:75-85.
    >> Share

  14. HAMILTON F, Lee TC, Davey Smith G, Hartwig FP, et al
    Does Piperacillin-Tazobactam Increase Mortality Risk Compared With Cefepime? Collider Bias and the Importance of Assumptions in Instrumental Variable Analyses.
    Clin Infect Dis. 2026;82:e17-e23.
    >> Share

    December 2025
  15. TANDE AJ, Stevens RW, Ilges D, Lahr BD, et al
    Cumulative Antibiotic Exposure Is Associated With Ceftriaxone Resistance Among Patients With Urinary Source Gram-negative Bloodstream Infection: A Retrospective Cohort Study.
    Clin Infect Dis. 2025;81:871-878.
    >> Share

  16. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
    Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Duration of Antibiotics for Complicated UTI.
    Clin Infect Dis. 2025 Dec 20:ciaf462. doi: 10.1093.
    >> Share

  17. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
    Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Timing of Intravenous to Oral Antibiotics Transition for Complicated UTI.
    Clin Infect Dis. 2025 Dec 19:ciaf461. doi: 10.1093.
    >> Share

    November 2025
  18. SWETS MC, Bakk Z, Westgeest AC, Ruffin F, et al
    Reproducible identification of Staphylococcus aureus bacteremia clinical subphenotypes.
    Clin Infect Dis. 2025 Nov 27:ciaf655. doi: 10.1093.
    >> Share

  19. MACVANE SH, Moon R, David J, Rosenthal N, et al
    Microbiology Laboratory Testing Practices of Gram-Negative Bloodstream Infections With Difficult-to-Treat Resistant Phenotypes in US Hospitals.
    Clin Infect Dis. 2025;81:710-720.
    >> Share

    October 2025
  20. FORD JS, Gross BJ, Nemati S, Malhotra A, et al
    Operationalizing Sepsis Definitions with Artificial Intelligence: Toward Smarter Antibiotic Use.
    Clin Infect Dis. 2025 Oct 31:ciaf601. doi: 10.1093.
    >> Share

  21. RHEE C, Klompas M
    Balancing Innovation in Artificial Intelligence with Practical Sepsis Definitions.
    Clin Infect Dis. 2025 Oct 31:ciaf602. doi: 10.1093.
    >> Share

    September 2025
  22. WALLS G, McGrath L, Herdman MT, Campbell AJ, et al
    Patient-reported perceptions, experiences and preferences around intravenous and oral antibiotics for the treatment of Staphylococcus aureus bacteremia: a descriptive qualitative study.
    Clin Infect Dis. 2025 Sep 24:ciaf522. doi: 10.1093.
    >> Share

  23. MANN SC, Lykins D, Coyle RP, Witt MD, et al
    In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort.
    Clin Infect Dis. 2025 Sep 17:ciaf509. doi: 10.1093.
    >> Share

    August 2025
  24. RADER A, Ruffin F, Fai C, Barton KD, et al
    A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Intraabdominal Infections.
    Clin Infect Dis. 2025;81.
    >> Share

  25. PEI PP, Jones M, Hu R, Chen W, et al
    Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US.
    Clin Infect Dis. 2025 Aug 4:ciaf428. doi: 10.1093.
    >> Share

  26. COLASANTI JA, Aldredge A, Niles-Carnes LV, Ochieng E, et al
    Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. South.
    Clin Infect Dis. 2025 Aug 1:ciaf425. doi: 10.1093.
    >> Share

    July 2025
  27. HURALSKA M, Pogue JM, Rybak M, Abdul-Mutakabbir JC, et al
    The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens.
    Clin Infect Dis. 2025 Jul 19:ciaf398. doi: 10.1093.
    >> Share

  28. TILANUS AM, Shields RK, Lodise TP, Drusano GL, et al
    Translating Pharmacokinetic-Pharmacodynamic Principles Into Improved Methodology for Clinical Trials That Compare Intermittent With Prolonged Infusion of Beta-Lactam Antibiotics.
    Clin Infect Dis. 2025;80:1275-1280.
    >> Share

    June 2025
  29. GUPTA S, Klompas M, Rhee C
    Reassessing Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients with Sepsis: Lessons from the ADAPT-Sepsis Trial.
    Clin Infect Dis. 2025 Jun 20:ciaf336. doi: 10.1093.
    >> Share

    May 2025
  30. LOOSLI T, Moore CB, Buzaalirwa L, Byakwaga H, et al
    Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study.
    Clin Infect Dis. 2025 May 20:ciaf204. doi: 10.1093.
    >> Share

  31. BALBUENA JP, Cordova E, Mykietiuk A, Farina J, et al
    Carbapenem-resistant Gram-negative bacilli bacteremia in Argentina (EMBARCAR): findings from a prospective, multicenter cohort study.
    Clin Infect Dis. 2025 May 20:ciaf259. doi: 10.1093.
    >> Share

  32. BROWN KA, Fridman DJ, Garber GE, Johnstone J, et al
    The Burden of Antimicrobial Resistant Bacteremia in Ontario: A Population-wide Analysis of Attributable Mortality from 110 Pathogen-Antibiotic Combinations.
    Clin Infect Dis. 2025 May 13:ciaf213. doi: 10.1093.
    >> Share

  33. CHEVALIER JM, Hansen MA, Blumel B, Chuchu V, et al
    Modeling the impact and cost of a culture-dependent molecular test for antimicrobial resistance in resource-limited settings.
    Clin Infect Dis. 2025 May 12:ciaf236. doi: 10.1093.
    >> Share

    April 2025
  34. PATANWALA AE, Nix DE, Hills TE, Erstad BL, et al
    A National Retrospective Cohort Study Comparing the Effects of Cefepime Versus Piperacillin-Tazobactam on the Development of Severe Acute Kidney Injury in Patients With Septic Shock.
    Clin Infect Dis. 2025;80:770-776.
    >> Share

  35. SHAPPELL CN, Yu T, Klompas M, Agan AA, et al
    Frequency of Antibiotic Overtreatment and Associated Harms in Patients Presenting With Suspected Sepsis to the Emergency Department: A Retrospective Cohort Study.
    Clin Infect Dis. 2025 Apr 15:ciaf118. doi: 10.1093.
    >> Share

  36. KLOMPAS M, Rhee C
    Revising sepsis definitions to better target and tailor sepsis care.
    Clin Infect Dis. 2025 Apr 10:ciaf187. doi: 10.1093.
    >> Share

    March 2025
  37. TALA-IGHIL T, Garcia-Hermoso D, Dalle F, Cassaing S, et al
    Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012-2022).
    Clin Infect Dis. 2025;80:529-539.
    >> Share

  38. PAPADIMITRIOU-OLIVGERIS M, Senn L, Guery B
    Validation of the proposed definition for complicated coagulase negative staphylococcal bacteremia.
    Clin Infect Dis. 2025 Mar 13:ciaf119. doi: 10.1093.
    >> Share

  39. KARCHMER AW, Kaufman NJ, Park SY, Modi RM, et al
    Quantitative Microbial Cell-Free DNA Sequencing from Plasma: A Potential Biomarker for the Diagnosis of Staphylococcal Infection of Cardiac Implantable Electronic Devices.
    Clin Infect Dis. 2025 Mar 11:ciaf113. doi: 10.1093.
    >> Share

    February 2025
  40. STEFANOVIC A, Alam ME, Matic N, Larnder A, et al
    Increased Severity of Multidrug-Resistant Shigella sonnei Infections in People Experiencing Homelessness.
    Clin Infect Dis. 2025;80:339-346.
    >> Share

  41. GARCIA R, Septimus EJ, LeDonne J, Sturm LK, et al
    Prevention of Vascular Access Device-Associated Hospital-Onset Bacteremia and Fungemia: A Review of Emerging Perspectives and Synthesis of Technical Aspects.
    Clin Infect Dis. 2025;80:444-450.
    >> Share

  42. SHAH S, Kline EG, Haidar G, Squires KM, et al
    Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia.
    Clin Infect Dis. 2025;80:24-28.
    >> Share

    January 2025
  43. CUNNINGHAM CA, Ilges D
    Epidemiology and Outcomes of Antibiotic De-escalation in Patients with Suspected Sepsis in US Hospitals.
    Clin Infect Dis. 2025 Jan 17:ciaf022. doi: 10.1093.
    >> Share

  44. KAM KQ, Klompas M, Rhee C
    Challenges and Opportunities in Leveraging Spectrum Scores to Assess Antibiotic De-escalation Practices and Outcomes in Sepsis.
    Clin Infect Dis. 2025 Jan 17:ciaf023. doi: 10.1093.
    >> Share

  45. VENA A, Tiseo G, Falcone M, Bartalucci C, et al
    Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter Study.
    Clin Infect Dis. 2025 Jan 15:ciae603. doi: 10.1093.
    >> Share

  46. MATELSKI A, Gregoire B, Beste LA, Varley CD, et al
    Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of U.S. Veterans.
    Clin Infect Dis. 2025 Jan 9:ciaf008. doi: 10.1093.
    >> Share

    December 2024
  47. RUFFIEUX Y, Mwansa-Kambafwile J, Metekoua C, Tombe-Nyahuma T, et al
    HIV-1 Viremia and Cancer Risk in 2.8 Million People: the South African HIV Cancer Match Study.
    Clin Infect Dis. 2024 Dec 30:ciae652. doi: 10.1093.
    >> Share

  48. STROMDAHL M, Hagman K, Hedman K, Westman A, et al
    Time to Staphylococcus aureus Blood Culture Positivity as a risk marker of Infective Endocarditis: A Retrospective Cohort Study.
    Clin Infect Dis. 2024 Dec 21:ciae628. doi: 10.1093.
    >> Share

  49. KAM KQ, Chen T, Kadri SS, Lawandi A, et al
    Epidemiology and Outcomes of Antibiotic De-escalation in Patients with Suspected Sepsis in US Hospitals.
    Clin Infect Dis. 2024 Dec 6:ciae591. doi: 10.1093.
    >> Share

  50. KONDO Y, Klompas M, McKenna CS, Pak TR, et al
    Association Between the Sequence of beta-lactam and Vancomycin Administration and Mortality in Patients with Suspected Sepsis.
    Clin Infect Dis. 2024 Dec 5:ciae599. doi: 10.1093.
    >> Share

    November 2024
  51. CAWCUTT KA, Kalil AC
    Is Antibiotic De-Escalation Safe and Beneficial to Patients with Sepsis?
    Clin Infect Dis. 2024 Nov 27:ciae592. doi: 10.1093.
    >> Share

  52. STAVROPOULOU E, Monney P, Tzimas G, Ianculescu N, et al
    Predictors of persistent fever among patients with suspected infective endocarditis: think outside the box.
    Clin Infect Dis. 2024 Nov 27:ciae588. doi: 10.1093.
    >> Share

  53. JIMENEZ A, Rosa R, Ayoub S, Guran R, et al
    Factors Associated With Poor Clinical and Microbiologic Outcomes in Candida auris Bloodstream Infection: A Multicenter Retrospective Cohort Study.
    Clin Infect Dis. 2024;79:1262-1268.
    >> Share

  54. LANZ C, Meier J, Stockle M, Furrer H, et al
    HIV-1 low-level viremia predicts viral failure in participants on antiretroviral therapy in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2024 Nov 21:ciae569. doi: 10.1093.
    >> Share

  55. DAVIS JM, Rana A, Sax PE, Bares SH, et al
    Long-Acting Cabotegravir Plus Rilpivirine in People with HIV with Adherence Challenges and Viremia: Current Data and Future Directions.
    Clin Infect Dis. 2024 Nov 12:ciae557. doi: 10.1093.
    >> Share

  56. DAILEY MP
    OPAT and Severe Sepsis Mortality.
    Clin Infect Dis. 2024 Nov 7:ciae553. doi: 10.1093.
    >> Share

    October 2024
  57. ONG SWX, Luo J, Fridman DJ, Lee SM, et al
    Association Between Infectious Diseases Consultation and Mortality in Hospitalized Patients With Gram-negative Bloodstream Infection: A Retrospective Population-wide Cohort Study.
    Clin Infect Dis. 2024;79:855-863.
    >> Share

  58. HICKEY MD, Gistand N, Grochowski J, Mayorga-Munoz F, et al
    48-week viral suppression rates in people with HIV starting long-acting CAB/RPV with initial viremia.
    Clin Infect Dis. 2024 Oct 5:ciae500. doi: 10.1093.
    >> Share

  59. TAYLOR SP, Palakshappa JA, Chou SH, Gibbs K, et al
    Development of an Electronic Clinical Surveillance Measure for Unnecessary Rapid Antibiotic Administration in Suspected Sepsis.
    Clin Infect Dis. 2024 Oct 3:ciae445. doi: 10.1093.
    >> Share

  60. VIRK HS, Biemond JJ, Earny VA, Chowdhury S, et al
    Unraveling Sepsis Epidemiology in a Low- and Middle-Income Intensive Care Setting Reveals the Alarming Burden of Tropical Infections and Antimicrobial Resistance: A Prospective Observational Study (MARS-India).
    Clin Infect Dis. 2024 Oct 1:ciae486. doi: 10.1093.
    >> Share

    September 2024
  61. WEN SCH, Harris PNA, Forde B, Permana B, et al
    Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes.
    Clin Infect Dis. 2024;79:734-743.
    >> Share

  62. GUTIERREZ F, Fernandez-Gonzalez M, Ledesma C, Losada-Echeberria M, et al
    Virological History Predicts Non-sustained Viral Suppression with Long-Acting Cabotegravir and Rilpivirine Therapy, independent of Pharmacokinetic Parameters.
    Clin Infect Dis. 2024 Sep 19:ciae475. doi: 10.1093.
    >> Share

  63. MOURAD A, Nwafo N, Skalla L, Holland TL, et al
    Oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis: a systematic review and meta-analysis of randomized controlled trials.
    Clin Infect Dis. 2024 Sep 18:ciae476. doi: 10.1093.
    >> Share

    August 2024
  64. PERI AM, Chatfield MD, Ling W, Furuya-Kanamori L, et al
    Rapid Diagnostic Tests and Antimicrobial Stewardship Programs for the Management of Bloodstream Infection: What Is Their Relative Contribution to Improving Clinical Outcomes? A Systematic Review and Network Meta-analysis.
    Clin Infect Dis. 2024;79:502-515.
    >> Share

  65. DUDOIGNON E, Camelena F, de Tymowski C, Lafaurie M, et al
    Shorter Versus Longer Course of Antibiotic Therapy for Gram-Negative Bacteremia: Time for a Tailored Duration?
    Clin Infect Dis. 2024;79:577-579.
    >> Share

    July 2024
  66. MAILLARD A, Dortet L, Delory T, Lafaurie M, et al
    Mutation Rate of AmpC beta-Lactamase-Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution.
    Clin Infect Dis. 2024;79:52-55.
    >> Share

  67. TEMKIN E, Solter E, Lugassy C, Chen D, et al
    The Natural History of Carbapenemase-Producing Enterobacterales: Progression From Carriage of Various Carbapenemases to Bloodstream Infection.
    Clin Infect Dis. 2024;79:22-29.
    >> Share

  68. GIANNELLA M, Pascale R, Viale P
    Progression From Carriage to Bloodstream Infection and Fatality by Different Enterobacterales Species, Carbapenemases, and Host Settings: Deciphering the Melting Pot.
    Clin Infect Dis. 2024;79:30-32.
    >> Share

  69. NUSSBAUM EZ, Koo S, Kotton CN
    Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study.
    Clin Infect Dis. 2024;79:208-214.
    >> Share

  70. SORIANO A, Honore PM, Cornely OA, Chayakulkeeree M, et al
    Treatment Outcomes Among Patients With a Positive Candida Culture Close to Randomization Receiving Rezafungin or Caspofungin in the ReSTORE Study.
    Clin Infect Dis. 2024 Jul 10:ciae363. doi: 10.1093.
    >> Share

    June 2024
  71. SWETS MC, Bakk Z, Westgeest AC, Berry K, et al
    Clinical sub-phenotypes of Staphylococcus aureus bacteraemia.
    Clin Infect Dis. 2024 Jun 25:ciae338. doi: 10.1093.
    >> Share

  72. OLADAPO-SHITTU O, Cosgrove SE, Rock C, Hsu YJ, et al
    Characterizing Patients Presenting on Hospital Admission With Central Line-Associated Bloodstream Infections: A Multicenter Study.
    Clin Infect Dis. 2024;78:1632-1639.
    >> Share

  73. ANKRAH PK, Bock A, Ruffin F, Hanson BM, et al
    Persistent Gram-negative Bloodstream Infection Increases the Risk of Recurrent Bloodstream Infection With the Same Species.
    Clin Infect Dis. 2024;78:1458-1461.
    >> Share

  74. HARDY M, Harris PNA, Paterson DL, Chatfield MD, et al
    Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial.
    Clin Infect Dis. 2024;78:1482-1489.
    >> Share

  75. SENCHYNA F, Murugesan K, Rotunno W, Nadimpalli SS, et al
    Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-beta-lactamase-Producing Escherichia coli Causing Fatal Bloodstream Infection.
    Clin Infect Dis. 2024;78:1425-1428.
    >> Share

  76. MORQUIN D, Lejeune J, Agostini C, Godreuil S, et al
    Time Is of the Essence: Achieving Prompt and Effective Antimicrobial Therapy of Bloodstream Infection With Advanced Hospital Information Systems.
    Clin Infect Dis. 2024;78:1434-1442.
    >> Share

  77. SKRIVANKOVA VW, Huwa J, Muula G, Chiwaya GD, et al
    Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia.
    Clin Infect Dis. 2024 Jun 7:ciae261. doi: 10.1093.
    >> Share

  78. TESHOME BF, Park T, Arackal J, Hampton N, et al
    Preventing New Gram-negative Resistance Through Beta-lactam De-escalation in Hospitalized Patients With Sepsis: A Retrospective Cohort Study.
    Clin Infect Dis. 2024 Jun 6:ciae253. doi: 10.1093.
    >> Share

  79. FOURRE N, Zimmermann V, Senn L, Monney P, et al
    Evaluation of the HANDOC score and the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with streptococcal bacteremia.
    Clin Infect Dis. 2024 Jun 6:ciae315. doi: 10.1093.
    >> Share

    May 2024
  80. ALEXANDRE M, Prague M, Lhomme E, Lelievre JD, et al
    Definition of Virological Endpoints Improving the Design of Human Immunodeficiency Virus (HIV) Cure Strategies Using Analytical Antiretroviral Treatment Interruption.
    Clin Infect Dis. 2024 May 31:ciae235. doi: 10.1093.
    >> Share

  81. ANPALAGAN K, Dotel R, MacFadden DR, Smith S, et al
    Does adjunctive clindamycin have a role in Staphylococcus aureus bacteremia? A protocol for the adjunctive treatment domain of the S. aureus Network Adaptive Platform (SNAP) randomized controlled trial.
    Clin Infect Dis. 2024 May 27:ciae289. doi: 10.1093.
    >> Share

  82. RUSSELL CD, Berry K, Cooper G, Sim W, et al
    Distinct clinical endpoints of Staphylococcus aureus bacteraemia complicate assessment of outcome.
    Clin Infect Dis. 2024 May 20:ciae281. doi: 10.1093.
    >> Share

  83. PINEDA-REYES R, Neil BH, Orndorff J, Williams-Bouyer N, et al
    Clinical presentation, antimicrobial resistance, and treatment outcomes of Aeromonas human infections: A 14-year retrospective study and comparative genomics of two isolates from fatal cases.
    Clin Infect Dis. 2024 May 17:ciae272. doi: 10.1093.
    >> Share

  84. HAREZA DA, Cosgrove SE, Simner PJ, Harris AD, et al
    Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum beta-Lactamase-Producing Enterobacterales Bloodstream Infections?
    Clin Infect Dis. 2024;78:1103-1110.
    >> Share

    April 2024
  85. SUNNERHAGEN T, Rasmussen M
    Lower specificity of the ESC2023 diagnostic criteria for infective endocarditis when spondylodiscitis is regarded as a vascular phenomenon.
    Clin Infect Dis. 2024 Apr 24:ciae223. doi: 10.1093.
    >> Share

  86. FIGGATT MC, Rosen DL, Chu VH, Wu LT, et al
    Long-term risk of serious infections and mortality among patients surviving drug use-associated infective endocarditis.
    Clin Infect Dis. 2024 Apr 20:ciae214. doi: 10.1093.
    >> Share

  87. QIU J, Zimmet AN, Bell TD, Gadrey S, et al
    Pathophysiological Responses to Bloodstream Infection in Critically Ill Transplant Recipients Compared With Non-Transplant Recipients.
    Clin Infect Dis. 2024;78:1011-1021.
    >> Share

  88. MAILLARD A, Micheli G, Lefevre L, Guyonnet C, et al
    Can Chatbot Artificial Intelligence Replace Infectious Diseases Physicians in the Management of Bloodstream Infections? A Prospective Cohort Study.
    Clin Infect Dis. 2024;78:825-832.
    >> Share

  89. HENDRIKS MMC, Schweren KSA, Kleij A, Berrevoets MAH, et al
    Low-risk Staphylococcus aureus bacteremia patients do not require routine diagnostic imaging: A multicenter retrospective cohort study.
    Clin Infect Dis. 2024 Apr 5:ciae187. doi: 10.1093.
    >> Share

  90. TSCHUMI N, Lukau B, Tlali K, Motaboli L, et al
    Emergence of acquired dolutegravir resistance in treatment-experienced people with HIV in Lesotho.
    Clin Infect Dis. 2024 Apr 3:ciae185. doi: 10.1093.
    >> Share

    March 2024
  91. FOURRE N, Zimmermann V, Senn L, Aruanno M, et al
    Predictors of mortality of streptococcal bacteremia and the role of infectious diseases consultation; a retrospective cohort study.
    Clin Infect Dis. 2024 Mar 25:ciae168. doi: 10.1093.
    >> Share

  92. FENG X, Qian C, Fan Y, Li J, et al
    Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis.
    Clin Infect Dis. 2024;78:518-525.
    >> Share

  93. SAKOULAS G, Tsou EE, Geriak M, Vasina L, et al
    Contemporary Management of Staphylococcus aureus Bacteremia: Some Additional Considerations for Clinicians.
    Clin Infect Dis. 2024 Mar 20:ciae080. doi: 10.1093.
    >> Share

    February 2024
  94. TINGSGARD S, Bastrup Israelsen S, Ostergaard C, Benfield T, et al
    Emulating a Target Trial of Shorter Compared to Longer Course of Antibiotic Therapy for Gram-Negative Bacteremia.
    Clin Infect Dis. 2024;78:292-300.
    >> Share

  95. PERI AM, O'Callaghan K, Rafiei N, Graves B, et al
    Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible Clinical Implications.
    Clin Infect Dis. 2024;78:283-291.
    >> Share

  96. LINDBERG H, Berge A, Jovanovic-Stjernqvist M, Hagstrand Aldman M, et al
    Performance of the 2023 Duke-ISCVID diagnostic criteria for infective endocarditis in relation to the modified Duke criteria and to clinical management- reanalysis of retrospective bacteremia cohorts.
    Clin Infect Dis. 2024 Feb 8:ciae040. doi: 10.1093.
    >> Share

  97. MCGUIRE E, Collin SM, Brown CS, Saito M, et al
    Community-acquired Staphylococcus aureus bacteraemia among people who inject drugs: a national cohort study in England, 2017-2020.
    Clin Infect Dis. 2024 Feb 5:ciae056. doi: 10.1093.
    >> Share

    January 2024
  98. WIDERSTROM M, Mortberg S, Magnusson M, Fjallstrom P, et al
    Treatment Outcome of Severe Respiratory Type B Tularemia Using Fluoroquinolones.
    Clin Infect Dis. 2024;78.
    >> Share

  99. FOWLER VG JR, Das AF, Lipka-Diamond J, Ambler JE, et al
    Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
    Clin Infect Dis. 2024 Jan 31:ciae043. doi: 10.1093.
    >> Share

  100. VARLEY CD, Lowy E, Cartwright EJ, Morgan TR, et al
    Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era.
    Clin Infect Dis. 2024 Jan 27:ciae025. doi: 10.1093.
    >> Share

  101. ROACH DJ, Sridhar S, Oliver E, Rao SR, et al
    Clinical and Genomic Characterization of a Cohort of Patients With Klebsiella pneumoniae Bloodstream Infection.
    Clin Infect Dis. 2024;78:31-39.
    >> Share

  102. FENG X, Qian C, Fan Y, Li J, et al
    The Necessity of Studying Antibiotic Duration in Acute Leukemia Patients With Pseudomonas aeruginosa Bloodstream Infection: A Response to Terada and Kanno.
    Clin Infect Dis. 2024 Jan 17:ciae013. doi: 10.1093.
    >> Share

  103. VAN GRIENSVEN J, van Henten S, Kibret A, Kassa M, et al
    Chronic high level parasitemia in HIV-infected individuals with or without visceral leishmaniasis in an endemic area in North-West Ethiopia: potential superspreaders?
    Clin Infect Dis. 2024 Jan 9:ciae002. doi: 10.1093.
    >> Share

  104. PAPADIMITRIOU-OLIVGERIS M, Monney P, Frank M, Tzimas G, et al
    Evaluation of the 2023 Duke-ISCVID and 2023 Duke-ESC clinical criteria for the diagnosis of infective endocarditis in a multicenter cohort of patients with Staphylococcus aureus bacteremia.
    Clin Infect Dis. 2024 Jan 3:ciae003. doi: 10.1093.
    >> Share

    December 2023
  105. VAN DER VAART TW, Prins JM, Goorhuis A, Lemkes BA, et al
    The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low MRSA prevalence.
    Clin Infect Dis. 2023 Dec 29:ciad784. doi: 10.1093.
    >> Share

  106. WESTGEEST AC, Lambregts MMC, Fowler VG Jr
    Reply to Robertson: True Staphylococcus aureus bacteremia.
    Clin Infect Dis. 2023 Dec 7:ciad753. doi: 10.1093.
    >> Share

  107. ROBERTSON P
    A need to consider divergence in definition of Staphylococcus aureus bacteraemia too.
    Clin Infect Dis. 2023 Dec 7:ciad751. doi: 10.1093.
    >> Share

    November 2023
  108. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice.
    Clin Infect Dis. 2023;77:1489-1491.
    >> Share

  109. PAPANICOLAOU GA, Avery RK, Cordonnier C, Duarte RF, et al
    Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir with Valganciclovir.
    Clin Infect Dis. 2023 Nov 30:ciad709. doi: 10.1093.
    >> Share

  110. ROGERS R, Rice LB
    Executive Summary: State-of-the-Art Review: Persistent Enterococcal Bacteremia.
    Clin Infect Dis. 2023 Nov 29:ciad613. doi: 10.1093.
    >> Share

  111. ROGERS R, Rice LB
    State-of-the-Art Review: Persistent Enterococcal Bacteremia.
    Clin Infect Dis. 2023 Nov 29:ciad612. doi: 10.1093.
    >> Share

  112. SHULDER S, Tamma PD, Fiawoo S, Dzintars K, et al
    Infectious Diseases Consultation Associated With Reduced Mortality in Gram-Negative Bacteremia.
    Clin Infect Dis. 2023;77:1234-1237.
    >> Share

  113. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.
    Clin Infect Dis. 2023 Nov 10:ciad500. doi: 10.1093.
    >> Share

    October 2023
  114. DE KRETSER D, Mora J, Bloomfield M, Campbell A, et al
    Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.
    Clin Infect Dis. 2023 Oct 31:ciad666. doi: 10.1093.
    >> Share

  115. HAMAD Y, Bell TD, Kadri SS
    Shifting Tides: Is It Time to Embrace Adjunctive Corticosteroids for Community-Acquired Pneumonia?
    Clin Infect Dis. 2023 Oct 25:ciad498. doi: 10.1093.
    >> Share

  116. DOERNBERG SB, Arias CA, Altman DR, Babiker A, et al
    Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
    Clin Infect Dis. 2023;77.
    >> Share

  117. RHEE C, Strich JR, Chiotos K, Classen DC, et al
    Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper.
    Clin Infect Dis. 2023 Oct 13:ciad447. doi: 10.1093.
    >> Share

    September 2023
  118. KINAMON T, Dagher M, Park L, Ruffin F, et al
    Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients With Staphylococcus aureus Bacteremia.
    Clin Infect Dis. 2023 Sep 25:ciad377. doi: 10.1093.
    >> Share

  119. ELEBYARY O, Fine N, Sun C, Saha ST, et al
    A Primed Neutrophil Subset Predicts the Risk of Bloodstream Infections in Allogeneic Hematopoietic Stem-Cell Transplant Patients: A Prospective Study.
    Clin Infect Dis. 2023;77:752-760.
    >> Share

  120. FIDALGO B, Morata L, Cardozo C, Del Rio A, et al
    Information Delay of Significant Bloodstream Isolates and Patient Mortality: A Retrospective Analysis of 6225 Adult Patients With Bloodstream Infections.
    Clin Infect Dis. 2023;77:680-686.
    >> Share

    August 2023
  121. LING L, Zhang JZ, Chang LC, Chiu LCS, et al
    Population sepsis incidence, mortality, and trends in Hong Kong between 2009-2018 using clinical and administrative data.
    Clin Infect Dis. 2023 Aug 19:ciad491. doi: 10.1093.
    >> Share

  122. SOTO CL, Hsu AJ, Lee JH, Dzintars K, et al
    Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
    Clin Infect Dis. 2023 Aug 16:ciad476. doi: 10.1093.
    >> Share

  123. DHALIWAL M, Daneman N
    Utility of Differential Time to Positivity in Diagnosing Central Line-Associated Bloodstream Infections: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2023;77:428-437.
    >> Share

  124. PAK TR, Young J, McKenna CS, Agan A, et al
    Risk of Misleading Conclusions in Observational Studies of Time-to-Antibiotics and Mortality in Suspected Sepsis.
    Clin Infect Dis. 2023 Aug 2:ciad450. doi: 10.1093.
    >> Share

    July 2023
  125. BEZERRA CLPAM, Dos Santos EL, Oliveira MS, Dias MBS, et al
    Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort.
    Clin Infect Dis. 2023;77.
    >> Share

  126. ROBINSON ML, Johnson J, Naik S, Patil S, et al
    Maternal Colonization Versus Nosocomial Transmission as the Source of Drug-Resistant Bloodstream Infection in an Indian Neonatal Intensive Care Unit: A Prospective Cohort Study.
    Clin Infect Dis. 2023;77.
    >> Share

  127. LEE TC, McDonald EG, Tong SYC
    Positron Emission Tomography in Staphylococcus aureus Bacteremia: Peeking Under the Covers.
    Clin Infect Dis. 2023;77:16-18.
    >> Share

    June 2023
  128. DYRHOVDEN R, Eagan TM, Flotten O, Siljan W, et al
    Pleural empyema caused by Streptococcus intermedius and Fusobacterium nucleatum - a distinct entity of pleural infections.
    Clin Infect Dis. 2023 Jun 22:ciad378. doi: 10.1093.
    >> Share

  129. ZEGGIL T, Dalton B
    beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients.
    Clin Infect Dis. 2023;76:2212-2213.
    >> Share

  130. WESTGEEST AC, Buis DTP, Sigaloff KCE, Ruffin F, et al
    Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care.
    Clin Infect Dis. 2023 Jun 13:ciad363. doi: 10.1093.
    >> Share

  131. MICHELOW IC, Obaro SK
    Unraveling neonatal sepsis: sharper tools needed for unexpected organisms.
    Clin Infect Dis. 2023 Jun 5:ciad338. doi: 10.1093.
    >> Share

  132. ERICSON JE, Burgoine K, Kumbakumba E, Ochora M, et al
    Neonatal Paenibacilliosis: Paenibacillus infection as a Novel Cause of Sepsis in Term Neonates with High Risk of Sequelae in Uganda.
    Clin Infect Dis. 2023 Jun 5:ciad337. doi: 10.1093.
    >> Share

    May 2023
  133. GALLAGHER JC
    Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time.
    Clin Infect Dis. 2023;76:1613-1614.
    >> Share

  134. CASTANHEIRA M, Mendes RE, Gales AC
    Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex.
    Clin Infect Dis. 2023;76.
    >> Share

    April 2023
  135. ADELMAN MW, Septimus EJ, Arias CA
    The accuracy of infection diagnoses among patients meeting Sepsis-3 criteria in the emergency department.
    Clin Infect Dis. 2023 Apr 24:ciad240. doi: 10.1093.
    >> Share

  136. ALVAREZ H, Mocroft A, Ryom L, Neesgaard B, et al
    Plasma HIV-1 RNA and CD4+ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study.
    Clin Infect Dis. 2023 Apr 13:ciad219. doi: 10.1093.
    >> Share

  137. PAI MP, Cojutti PG, Gerussi V, Della Siega P, et al
    Linezolid Population Pharmacokinetics to Improve Dosing in Cardiosurgical Patients: Factoring a New Drug-Drug Interaction Pathway.
    Clin Infect Dis. 2023;76:1173-1179.
    >> Share

    March 2023
  138. FUJII K, Takada T, Kamitani T, Aoki T, et al
    Diagnostic Performance of Physician Gestalt for Bacteremia in Patients in the Process of Being Admitted With Suspected Infection.
    Clin Infect Dis. 2023;76:1074-1079.
    >> Share

  139. FRELING S, Wald-Dickler N, Banerjee J, Canamar CP, et al
    Real-world Application of Oral Therapy for Infective Endocarditis: A Multicenter Retrospective, Cohort Study.
    Clin Infect Dis. 2023 Mar 7:ciad119. doi: 10.1093.
    >> Share

  140. VAN DER VAART TW, Prins JM, van Werkhoven CH, Ten Doesschate T, et al
    Positive impact of [18F]FDG-PET/CT on mortality in patients with Staphylococcus aureus bacteremia explained by immortal time bias.
    Clin Infect Dis. 2023 Mar 4:ciad112. doi: 10.1093.
    >> Share

  141. COLE JC, Jankowski CA, Verdecia JL, Isache CL, et al
    The time for action is now: the impact of timing of infectious disease consultation for Staphylococcus aureus bacteremia.
    Clin Infect Dis. 2023 Mar 3:ciad110. doi: 10.1093.
    >> Share


  142. Correction to: Identifying Sepsis From Foodborne Hospitalization: Incidence and Hospitalization Cost by Pathogen.
    Clin Infect Dis. 2023 Mar 1:ciac507. doi: 10.1093.
    >> Share

    February 2023
  143. FALCONE M, Tiseo G, Carbonara S, Marino A, et al
    Mortality attributable to bloodstream infections caused by different carbapenem-resistant Gram negative bacilli: results from a nationwide study in Italy (ALARICO Network).
    Clin Infect Dis. 2023 Feb 21:ciad100. doi: 10.1093.
    >> Share

  144. BARBER BE, Abd-Rahman AN, Webster R, Potter AJ, et al
    Characterizing the blood stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum.
    Clin Infect Dis. 2023 Feb 16:ciad075. doi: 10.1093.
    >> Share

  145. PHONGKHUN K, Pothikamjorn T, Srisurapanont K, Manothummetha K, et al
    Prevalence of ocular candidiasis and Candida endophthalmitis in patients with candidemia: A systematic review and meta-analysis.
    Clin Infect Dis. 2023 Feb 8:ciad064. doi: 10.1093.
    >> Share

    January 2023
  146. MCATEER J, Lee JH, Cosgrove SE, Dzintars K, et al
    Defining the Optimal Duration of Therapy for Hospitalized Patients with Complicated Urinary Tract Infections and Associated Bacteremia.
    Clin Infect Dis. 2023 Jan 12:ciad009. doi: 10.1093.
    >> Share

  147. LEVI LI, Molina JM
    Cytomegalovirus (CMV) viremia in people with Human Immunodeficiency Virus (HIV): should we treat the CMV? Or the HIV? or Both?
    Clin Infect Dis. 2023 Jan 10:ciad011. doi: 10.1093.
    >> Share

  148. BLANC P, Bonnet F, Leleux O, Perrier A, et al
    Severe bacterial non-AIDS infections in persons with HIV: the epidemiology and evolution of antibiotic resistance over an 18-year period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine cohort.
    Clin Infect Dis. 2023 Jan 4:ciac978. doi: 10.1093.
    >> Share

    December 2022
  149. FUKUDA N, Balikagala B, Ueno T, Anywar DA, et al
    The impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa.
    Clin Infect Dis. 2022 Dec 15:ciac944. doi: 10.1093.
    >> Share

    November 2022
  150. RUFFIN F, Dagher M, Park LP, Wanda L, et al
    Black and White Patients with Staphylococcus aureus Bacteremia have Similar Outcomes but Different Risk Factors.
    Clin Infect Dis. 2022 Nov 14. pii: 6826998. doi: 10.1093.
    >> Share

    July 2022
  151. GREEN EW, Ndiaye M, Hossain IM, Olatunji YA, et al
    Pneumonia, meningitis, and septicaemia in adults and older children in rural Gambia: eight years of population-based surveillance.
    Clin Infect Dis. 2022 Jul 29. pii: 6651447. doi: 10.1093.
    >> Share

    June 2022
  152. ANDAGALU B, Watson OJ, Onyango I, Opot B, et al
    Malaria Transmission Dynamics in High Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-lumefantrine in an Asymptomatic Population.
    Clin Infect Dis. 2022 Jun 29. pii: 6619621. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016